QC
RXST icon

Quadrature Capital’s RxSight RXST Stock Holding History

Quadrature Capital’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
+43,043
New +$260K ﹤0.01% 1346
2025
Q4 		– Sell
-10,631
Closed -$95.6K – 1595
2025
Q3 		$95.6K Sell
10,631
-14,683
-58% -$129K ﹤0.01% 883
2025
Q2 		$329K Buy
25,314
+13,621
+116% +$205K 0.01% 672
2025
Q1 		$295K Buy
+11,693
New +$347K 0.01% 738

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quadrature Capital's RXST Position: Q2 2026 in Review

Quadrature Capital opened a new position in RxSight (RXST) in Q2 2026: 43,043 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #1346 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in RXST as recently as Q3 2025.

Quadrature Capital first reported a position in RXST in Q1 2025 and has held it in 4 quarters since. The position peaked at $329K in Q2 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Quadrature Capital held 43,043 shares of RxSight worth $207K as of Q2 2026.
  • RxSight was a new Quadrature Capital position in Q2 2026.
  • RxSight made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1346 holding.
  • Quadrature Capital first reported a position in RxSight in Q1 2025 and has held it in 4 quarters since.
  • Quadrature Capital's RxSight position peaked at $329K in Q2 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.